Positron Emission Tomography/Computed Tomography in the Management of Hodgkin's Disease and Non-Hodgkin's Lymphoma

被引：10

作者：

Rodriguez-Vigil, Beatriz ^{[1
]}

Gomez-Leon, Nieves ^{[1
]}

Pinilla, Inmaculada ^{[1
]}

Hernandez-Maraver, Dolores ^{[2
]}

Coya, Juan ^{[3
]}

Martin-Curto, Luis ^{[3
]}

机构：

[1] Univ Hosp La Paz, Dept Radiol, Paseo Castellana 261, Madrid 28046, Spain

[2] Univ Hosp La Paz, Dept Haematol, Madrid, Spain

[3] Univ Hosp La Paz, Dept Nucl Med, Madrid, Spain

来源：

CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY | 2006年 / 35卷 / 04期

关键词：

D O I：

10.1067/j.cpradiol.2006.02.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The incidence of Hodgkin's disease (HD) and Non-Hodgkin's lymphoma (NHL) is around 8% of all malignancies. Fortunately, HD and NHL are among the few malignancies that are potentially curable with current existing treatment modalities, even in advanced or recurrent disease. Accurate staging, early therapy monitoring, and posttreatment evaluation of lymphomas are important for optimum management of these patients. We reviewed the imaging findings of patients with histologically proved lymphoma who underwent staging positron emission tomography/computed tomography (PET/CT), early monitoring therapy PET/CT (after 3 cycles of chemotherapy), and posttreatment PET/CT. PET/CT imaging findings are shown. Utility of PET/CT in recognizing false-positive and falsenegative cases of CT and PET alone is addressed. Pitfalls and diagnostic difficulties are analyzed. PET/CT is a new imaging technology that improves the evaluation of lymphoma. This review will help the reader to better understand the imaging findings and applications of PET/CT in the management of lymphoma.

引用

页码：151 / 163

页数：13

共 47 条

[1] Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma [J].

Allen-Auerbach, M ;

Quon, A ;

Weber, WA ;

Obrzut, S ;

Crawford, T ;

Silverman, DHS ;

Ratib, O ;

Phelps, ME ;

Czernin, J .

MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (06) :411-416

[2]

Antoch G, 2004, J NUCL MED, V45, p56S

[3] Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials [J].

Antoch, G ;

Freudenberg, LS ;

Stattaus, J ;

Jentzen, W ;

Mueller, SP ;

Debatin, JF ;

Bockisch, A .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) :1555-1560

[4]

Antoch G, 2003, ELEKTROMEDICA, V71, P64

[5]

Bar-Shalom R, 2003, J NUCL MED, V44, P1200

[6]

Beyer T, 2005, J NUCL MED, V46, P429

[7]

Beyer T, 2000, J NUCL MED, V41, P1369

[8] Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT [J].

Bristow, RE ;

del Carmen, MG ;

Pannu, HK ;

Cohade, C ;

Zahurak, ML ;

Fishman, EK ;

Wahl, RL ;

Montz, FJ .

GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :519-528

[9] Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma:: prevalence and scan interpretation [J].

Castellucci, P ;

Nanni, C ;

Farsad, M ;

Alinari, L ;

Zinzani, P ;

Stefoni, V ;

Battista, G ;

Valentini, D ;

Pettinato, C ;

Marengo, M ;

Boschi, S ;

Canini, R ;

Baccarani, M ;

Monetti, N ;

Franchi, R ;

Rampin, L ;

Fanti, S ;

Rubello, D .

NUCLEAR MEDICINE COMMUNICATIONS, 2005, 26 (08) :689-694

[10] Image analysis in patients with cancer studied with a combined PET and CT scanner [J].

Charron, M ;

Beyer, T ;

Bohnen, NN ;

Kinahan, PE ;

Dachille, M ;

Jerin, J ;

Nutt, R ;

Meltzer, CC ;

Villemagne, V ;

Townsend, DW .

CLINICAL NUCLEAR MEDICINE, 2000, 25 (11) :905-910

← 1 2 3 4 5 →